Do all patients with breast cancer require systemic adjuvant therapy?
- PMID: 21881041
- PMCID: PMC3176780
- DOI: 10.1093/jnci/djr331
Do all patients with breast cancer require systemic adjuvant therapy?
Comment on
-
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88. doi: 10.1093/jnci/90.18.1371. J Natl Cancer Inst. 1998. PMID: 9747868 Clinical Trial.
Similar articles
-
Tamoxifen Breast Cancer Prevention Trial--an update.Prog Clin Biol Res. 1997;396:271-82. Prog Clin Biol Res. 1997. PMID: 9108604 Clinical Trial. No abstract available.
-
Can mammographic densities predict effects of tamoxifen on the breast?J Natl Cancer Inst. 1996 Jan 17;88(2):128-9. doi: 10.1093/jnci/88.2.128-a. J Natl Cancer Inst. 1996. PMID: 8537975 No abstract available.
-
Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Natl Cancer Inst. 1999 Apr 21;91(8):730. doi: 10.1093/jnci/91.8.730. J Natl Cancer Inst. 1999. PMID: 10218518 No abstract available.
-
[Tamoxifen and breast cancer: is everything known already?].Tumori. 1998 Nov-Dec;84(6):A1-5. Tumori. 1998. PMID: 10080686 Review. Italian. No abstract available.
-
Tamoxifen in cancer therapy: minireview.Neoplasma. 2000;47(1):3-7. Neoplasma. 2000. PMID: 10870680 Review.
References
-
- Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792. - PubMed
-
- Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717. - PubMed
-
- Cortes J, Saura C, Bellet M, et al. HER2 and hormone receptor-positive breast cancer—blocking the right target. Nat Rev Clin Oncol. 2011;8(5):307–311. - PubMed
-
- Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998;16(2):515–521. - PubMed
-
- Lindley C, Vasa S, Sawyer WT, et al. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998;16(4):1380–1387. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical